Optimized reference region and the effect on test-retest reliability and sensitivity to differences between Parkinson’s disease and control groups with [ 11 C]UCB-J

Read full text
Authors: Nikkita Khattar, David Matuskey, Jean-Dominique Gallezot, Mika Naganawa, Sophie E. Holmes, Faranak Ebrahimian Sadabad, Mahsa Mayeli, Irina Esterlis, Christopher H. van Dyck, Adam P. Mecca, Deepak Cyril D’Souza, Nabeel Nabulsi
+4 more Sjoerd J. Finnema, Yiyun Henry Huang, Richard E. Carson, Takuya Toyonaga
Cited by: 1
References: 42

Abstract

[ 11 C]UCB-J is a radioligand targeting synaptic vesicle glycoprotein 2A, used to image synaptic density. For quantification, a small-volume centrum semiovale area was previously optimized as a [ 11 C]UCB-J reference region (CS2mL); however, due to its small volume, its high variability resulted in reduced reliability. Herein, we evaluated an alternative reference region method to assess longitudinal test-retest reliability and detection of Parkinson’s disease (PD). For estimating distribution volume ratio (DVR), CS2mL and eleven white matter (WM) reference regions (range: 0.5–200 mL) were generated. Same-day and longitudinal test-retest variability (TRV) were assessed (24 healthy subjects (HS); n = 10 same-day and n = 20 longitudinal scans, range: 7–1028 days). Each reference region was used to evaluate the substantia nigra (SN) and caudate DVRs in HS ( n = 25) and PD ( n = 20); 10 mL was the optimal reference region volume, yielding [ 11 C]UCB-J DVR measurements with reduced variability in TRV (same-day: 10 mL: 1.2 ± 5.7%, same-day: CS2mL: −0.9 ± 9.2% longitudinal: 10 mL: 1.5 ± 7.0%, CS2mL: 1.6 ± 11.9%), while maintaining

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Neuroscience and Neuropharmacology Research Neurological disorders and treatments

Publication details

Journal / source
Journal of Cerebral Blood Flow & Metabolism
Publisher
SAGE Publications
Volume
46
Issue
9
Pages
2302–2311
Publication date
10 April 2026
Language
EN